WASHINGTON -- In this exclusive press conference, Dr. Smits presents two-year results from a prospective randomized trial of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.
WASHINGTON -- In this exclusive press conference, Dr. Smits presents two-year results from a prospective randomized trial of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.